News

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...
Talin is a protein that plays an important role in the immune system by activating integrins, receptors that help cells ...
Ultimate Staffing Services, a business line of Roth Staffing Companies, has been awarded on the Forbes list of America's Best Recruiting and Temporary Staffing Firms 2025. This prestigious award is ...
Orchestra BioMed holds two best-in-class medical device therapies targeting large markets. Find out why OBIO stock is a Buy.
Mr. Altha Gene “Bo” Brantley, age 87, passed away Monday, May 26, 2025, at an Alabama hospital.
Market Value and Growth In 2025, the Gene Therapy For Rare Disease Market Size is valued at approximately US$ 3.01 Billion in 2024, marking a substantial increase from previous years. This growth ...
The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Iovance Biotherapeutics, Inc. ("Iovance" ...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit ...
GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, today announced that Dr. Kristopher Wentzel ...
Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s ...
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is leading the way with innovative therapies for rare and difficult-to-treat diseases, particularly early-stage cutaneous T-cell ...
Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the deliver ...